All Stories

  1. An integrated NMR and DFT study on the conformational preferences of N-alkyl benzamides
  2. Modulating Luminescence Thermometry of the Eu III /Tb III Pair in Coordination Polymers through Ligand Structure and Lanthanide(III) Molar Ratio
  3. A serendipitous product of the reaction of famotidine with copper(II)
  4. Structural, supramolecular analysis, and photoluminescence properties of a new hydroxybenzohydrazide Schiff base
  5. Copper(II)-5-chloro-2-hydroxybenzophenone Complexes with N – N Donors: Structural Insights and Antitumor Activity against A2780 Human Ovarian Cancer Cells of ...
  6. An integrated NMR and DFT study on the conformational preferences of N-alkyl benzamides
  7. Para -substituted benzoic acid ruthenium( ii ) complexes: structural features modulating cytotoxicity
  8. Elucidating thermally activated luminescence quenching in Eu III β-diketonate complexes as crystals or polymeric films for application in thermometry
  9. Manganese‐Induced Production of Antioxidant Polyene Steroids in the Extremophile Fungus Talaromyces fuscoviridis Isolated From Copper‐Mine Soil
  10. New Naphthoquinone‐Based Manganese (II) Complexes: Synthesis, Characterization, and Cytotoxicity
  11. Use of computational techniques in Raman spectra analysis
  12. Ascorbyl Radicals as Reducing Agents in Copper-Catalyzed Redox Reactions
  13. The Vortex-Slurry Implementation: A Cheap, Easy, and Ultrafast Mechanochemical Tool to Synthesize/Screen Pharmaceutical Salts and Cocrystals
  14. A supersaturated glass-melt approach for growing micrometer-sized TGG single crystals
  15. Enhanced Anticancer Potential of Pd(II)-Thiosemicarbazone Complexes: Selectivity, Mechanisms, and 3D Models
  16. Innovative synthesis of Tm³⁺/Er³⁺-doped Yb-YGG single crystals for upconversion-based white light emission
  17. Ru(II)-Fenamic-Based Complexes as Promising Human Ovarian Antitumor Agents: DNA Interaction, Cellular Uptake, and Three-Dimensional Spheroid Models
  18. A new anthelmintic salt
  19. Enhancing physicochemical properties of hydrochlorothiazide with zwitterionic L-proline and 5-fluorocytosine cocrystals through mechanochemical synthesis
  20. Ruthenium(II) Complex with 1-Hydroxy-9,10-Anthraquinone Inhibits Cell Cycle Progression at G0/G1 and Induces Apoptosis in Melanoma Cells
  21. A novel imatinib analogue inhibitor of chronic myeloid leukaemia: design, synthesis and characterization—explanation of its folded conformation
  22. A nickel glutamate metal biomolecule framework
  23. Dual spectral and temporal encoding in luminescent polymeric films using a EuIII complex and a persistent phosphor for anti-counterfeiting applications
  24. Reactions of ketosulfoxonium ylides with allylic carbocations: stereoselective and direct access to highly-substituted cyclo-propanes and α-alkylated ylides
  25. Diastereoselective Synthesis of Highly Functionalized γ‐Lactams via Ugi Reaction/Michael Addition
  26. A new ciprofibrate calcium salt with improved solubility and intrinsic dissolution rate
  27. NMR and X-ray diffraction conformational study of guanidines
  28. Synthesis, XRD structural analysis and theoretical studies of a potential inhibitor against rheumatoid arthritis (RA)
  29. Reactivity of the p‐Cymene‐Ruthenium Complex with Two Phenylamines for Metathesis Polymerization of Norbornene Compared to the Reactivity of Complexes with a Single Benzylamine or Dibenzylamine
  30. Structural Properties and Charge Redistribution in Cocrystallized Pharmaceutical Ingredients: A Comparative Experimental and Theoretical Charge Density Analysis
  31. Synthesis, characterization and structural analysis of complexes from 2,2′:6′,2′′-terpyridine derivatives with transition metals
  32. Controlled synthesis and structure characterization of a new fluconazole polymorph using analytical techniques and multivariate method
  33. Study of the Conformation of Bromated Guanidines with Potential Anti-leishmania Activity
  34. Use of Mechanochemical Methodology to Explore the Formation of a New Crystalline Phase in the Curcumin‐Quercetin System
  35. Intensity and lifetime ratiometric luminescent thermometer based on a Tb(iii) coordination polymer
  36. Versatile Applications of Cyanoacetic Acid in Organic Chemistry: Active Methylene Compound for the Knoevenagel Condensation and Organocatalyst for the Biginelli Reaction
  37. Structural and Anticancer Studies of Methoxyflavone Derivative from Strychnos pseudoquina A.St.-Hil. (Loganiaceae) from Brazilian Cerrado
  38. Synthesis, Characterization, DNA Binding and Cytotoxicity of Copper(II) Phenylcarboxylate Complexes
  39. Synthesis, Characterization and Structural Analysis of Two New Biguanide Complexes
  40. Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution
  41. Nitrosyl/Diphenylphosphine/Amino Acid–Ruthenium Complexes as Inhibitors of MDA-MB-231 Breast Cancer Cells
  42. Molecular structure of Ru(II)/diphosphine/4,6-dimethyl-2-pyrimidinethiol complexes: A combined experimental and density functional theory study
  43. Drug Repurposing of the Antiviral Drug Acyclovir: New Pharmaceutical Salts
  44. Development of Copper Complexes with Diimines and Dipicolinate as Anticancer Cytotoxic Agents
  45. “Half-Sandwich” Ruthenium Complexes with Alizarin as Anticancer Agents: In Vitro and In Vivo Studies
  46. Tuning the Thermometric Features in 1D Luminescent EuIII and TbIII Coordination Polymers through Different Bridge Phosphine Oxide Ligands
  47. It Takes Two to Tango, Part II: Synthesis of A-Ring Functionalised Quinones Containing Two Redox-Active Centres with Antitumour Activities
  48. New Copper(II)-L-Dipeptide-Bathophenanthroline Complexes as Potential Anticancer Agents—Synthesis, Characterization and Cytotoxicity Studies—And Comparative DNA-Binding Study of Related Phen Complexes
  49. Spontaneous Resolution of RS-Fluoxetine to a Racemic Conglomerate upon Salt Formation with Oxalic Acid
  50. Activation–Deactivation of Inter-Peptide Bond in Fluoro-N-(2-hydroxy-5-methyl phenyl)benzamide Isomers, Induced by the Position of the Halogen Atom in the Benzene Ring
  51. Highlighting Recent Crystalline Engineering Aspects of Luminescent Coordination Polymers Based on F-Elements and Ditopic Aliphatic Ligands
  52. Synthesis and Evaluation of Antibacterial Activity of 1,2,3-Triazole and Ether Derivatives of Paeonol
  53. Roméite-Group Minerals Review: New Crystal Chemical and Raman Data of Fluorcalcioroméite and Hydroxycalcioroméite
  54. Vibrational and conformational analysis of structural phase transition in Estradiol 17β valerate with temperature
  55. Estudio estructural y supramolecular del ácido 2-E-((4-hidroxifenil) diazenil) benzoico
  56. Crystal Engineering in the design of New Solid Pharmaceutical Forms with enhanced pharmaceutical properties
  57. Amino–Imino Tautomerism in the Salt Formation of Albendazole: Hydrobromide and Nitrate Salts
  58. Glycosylated narciclasine alkaloid in Hippeastrum puniceum (Lam.) Kuntze
  59. Synthesis and X-ray crystal structures of polyfunctionalized 4H-chromene derivatives via tricomponent reaction with Knoevenagel adducts as intermediates in aqueous medium
  60. Molecular Structure Studies on Allyl Sulfonamides: Synthesis, Theoretical Treatment and Evaluation of Biological Activity
  61. meso-Tetra-(4-pyridyl)porphyrin/palladium(ii) complexes as anticancer agents
  62. Study of secondary porosity by SAXS and N 2 adsorption in composite materials obtained from a Cuban natural clinoptilolite
  63. Silver complexes with fluoroanthranilic acid isomers: Spectroscopic characterization, antimycobacterial activity and cytotoxic studies over a panel of tumor cells
  64. Synthesis and structural characterization of a series of ternary copper(II)-L-dipeptide-neocuproine complexes. Study of their cytotoxicity against cancer cells including MDA-MB-231, triple negative breast cancer cells
  65. Zeolite/ZnO composites based on a Cuban natural clinoptilolite and preliminary evaluation in methylene blue adsorption
  66. Biguanide–transition metals complexes as potential drug for hyperglycemia treatment
  67. Chain-like uranyl-coordination polymer as a bright green light emitter for sensing and sunlight driven photocatalysis
  68. Chemical transformation of a luminescent two-dimensional Eu(iii) coordination polymer in the aqueous phase
  69. Crystal structure, anti-Trypanosoma cruzi and cytotoxic activities of Cu(II) complexes bearing β-diketone and α-diimine ligands
  70. New Allyldithiocarbimates: Synthesis, Structure and Antifungal Activity against Phakopsora pachyrhizi and Hemileia vastatrix
  71. Synthesis and solid-state characterization of diclofenac imidazolium monohydrate: an imidazolium pharmaceutical ionic liquid
  72. “Half-Sandwich”/RuII Anticancer Complexes Containing Triphenylphosphine and p-Substituted Benzoic Acids
  73. Silver(i) complexes of 3-methoxy-4-hydroxybenzaldehyde thiosemicarbazones and triphenylphosphine: structural, cytotoxicity, and apoptotic studies
  74. Rational design, supramolecular synthesis and solid state characterization of two bicomponent solid forms of mebendazole
  75. Green One-Pot Asymmetric Synthesis of Peptidomimetics via Sequential Organocatalyzed Aziridination and Passerini Multicomponent Reaction
  76. Data of synthesis, characterization and luminescence measurements in 1D lanthanide coordination polymers based on lanthanides
  77. Synthesis, spectroscopic (FT–IR and UV–Vis), crystallographic and theoretical studies, and a molecular docking simulation of an imatinib-like template
  78. Green Synthetic Methodology of (E)-2-cyano-3-aryl Selective Knoevenagel Adducts Under Microwave Irradiation
  79. Ru(II) complexes containing uracil nucleobase analogs with cytotoxicity against tumor cells
  80. THERMAL BEHAVIOR OF INOSINE 5’-MONOPHOSPHATE COMPLEXES WITH COBALT(II), NICKEL(II), COPPER(II) AND CADMIUM(II) CATIONS
  81. Crystal structures of two CuII compounds: catena-poly[[chloridocopper(II)]-μ-N-[ethoxy(pyridin-2-yl)methylidene]-N′-[oxido(pyridin-3-yl)methylidene]hydrazine-κ4 N,N′,O:
  82. 1D lanthanide coordination polymers based on lanthanides and 4′-hydroxi-4-biphenylcarboxylic acid: Synthesis, structures and luminescence properties
  83. Synthesis, structural characterization, and theoretical studies of new pyrazole (E)-2-{[(5-(tert-butyl)-1H-pyrazol-3-yl)imino]methyl}phenol and (E)-2-{[(1-(4-bromophenyl)-3-(tert-butyl)-1H-pyrazol-5-yl]imino]methyl}phenol
  84. Isolation, Identification, Predictions of Biological Activity and Molecular Docking of the Diterpene Jateorin Obtained from the Stem of Odontocarya tamoides (D.C.) Miers
  85. A simple alternative to prodrug: The hydrochloride salt monohydrate of the prostate anticancer drug abiraterone
  86. Ru(II)/N-N/PPh3 complexes as potential anticancer agents against MDA-MB-231 cancer cells (N-N = diimine or diamine)
  87. Nickel complexes with phosphines and N-R-sulfonyldithiocarbimates ligands: New antifungals for the control of Hemileia vastatrix and Phakopsora pachyrhizi
  88. Fluconazole: Synthesis and Structural Characterization of Four New Pharmaceutical Cocrystal Forms
  89. Esterification of the free carboxylic group from the lutidinic acid ligand as a tool to improve the cytotoxicity of Ru(ii) complexes
  90. X-ray diffraction, vibrational and thermal study of dibenzazepinodione, a pharmacopeial impurity of oxcarbazepine
  91. Fluconazolium oxalate: synthesis and structural characterization of a highly soluble crystalline form
  92. When Serendipity Knocks on the Door: Synthesis and Physicochemical Characterization of 7-Chloro-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidin-5-one
  93. Pharmaceutical paroxetine-based organic salts of carboxylic acids with optimized properties: the identification and characterization of potential novel API solid forms
  94. Supramolecular synthesis and characterization of crystalline solids obtained from the reaction of 5-fluorocytosine with nitro compounds
  95. Highly water soluble agrichemicals by using engineered organic salts for reducing adverse environmental impacts
  96. APLICAÇÃO DA ESPECTROSCOPIA RAMAN NA CARACTERIZAÇÃO DE MINERAIS PERTENCENTES A UMA GEOCOLEÇÃO
  97. In vitro Antiplasmodial Activities of Alkaloids Isolated from Roots of Worsleya procera (Lem.) Traub (Amaryllidaceae)
  98. In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex
  99. In vitro cytotoxicity and in vivo zebrafish toxicity evaluation of Ru(ii)/2-mercaptopyrimidine complexes
  100. Spergulagenic Acid A: Isolation and single crystal structure elucidation
  101. Modulating the water solubility and thermal stability of the anti-tuberculosis drug Isoniazid via multicomponent crystal formation
  102. Development of copper(II)-diimine-iminodiacetate mixed ligand complexes as potential antitumor agents
  103. The use of variable temperature 13 C solid-state MAS NMR and GIPAW DFT calculations to explore the dynamics of diethylcarbamazine citrate
  104. In vitro leishmanicidal activity and theoretical insights into biological action of ruthenium(II) organometallic complexes containing anti-inflammatories
  105. Rational Design of a Famotidine–Ibuprofen Coamorphous System: An Experimental and Theoretical Study
  106. Crystal Structure of N-(2-Cyano-1-Phenylprop-2-en-1-yl)-4-Methylbenzenesulfonamide
  107. Mechanochemical Synthesis of a Multicomponent Solid Form: The Case of 5-Fluorocytosine Isoniazid Codrug
  108. Synthesis, crystal structure, photophysical properties and theoretical studies of a novel bis(phenylisoxazolyl) benzene derivative
  109. Co-crystal structure of a dinuclear (Zn-Y) and a trinuclear (Zn-Y-Zn) complexes derived from a Schiff base ligand
  110. 5-Fluorocytosine/5-Fluorouracil Drug-Drug Cocrystal: a New Development Route Based on Mechanochemical Synthesis
  111. Protonation of inorganic 5-Fluorocytosine salts
  112. Synthesis, characterization and solubility of a new anthelmintic salt: Mebendazole nitrate
  113. Novel Solid Solution of the Antiretroviral Drugs Lamivudine and Emtricitabine
  114. Cytotoxic activity and structural features of Ru(II)/phosphine/amino acid complexes
  115. Paroxetine and Fluoxetine Hexafluorosilicate salts: Synthesis, crystal structure, Hirshfeld surface, and supramolecular analysis
  116. {1-[1-(2-Hydroxyphenyl)ethylidene]-2-(pyridin-2-yl-κN)hydrazine-κ2 N′,O}{1-[1-(2-oxidophenyl)ethylidene]-2-(pyridin-2-yl-κN)hydrazine-κ2 N′,O}nickelate(...
  117. Antimicrobial activity of cis -[Ru(bpy) 2 (L)(L′)] n + complexes, where L = 4-(4-chlorobenzoyl)pyridine or 4-(benzoyl)pyridine and L′ = Cl − or CO
  118. Crystalline structure of the marketed form of Rifampicin: a case of conformational and charge transfer polymorphism
  119. Novel Isoniazid cocrystals with aromatic carboxylic acids: Crystal engineering, spectroscopy and thermochemical investigations
  120. Ru(ii)–thyminate complexes: new metallodrug candidates against tumor cells
  121. A vanillin-based copper(ii) metal complex with a DNA-mediated apoptotic activity
  122. Avoiding irreversible 5-fluorocytosine hydration via supramolecular synthesis of pharmaceutical cocrystals
  123. Facile Synthesis and Characterization of Symmetric N-[(Phenylcarbonyl) carbamothioyl]benzamide Thiourea: Experimental and Theoretical Investigations
  124. Exploring physical and chemical properties in new multifunctional indium-, bismuth-, and zinc-based 1D and 2D coordination polymers
  125. Crystal engineering of multicomponent crystal forms of antituberculosis drugs
  126. Crystallochemical characterization of polyoxometalate new minerals
  127. Synthesis, characterization and reactivity of halides/pseudohalides and their complexes containing ruthenium II in the hydrogenation of cyclohexene
  128. Conformational and structural diversity of iridium dimethyl sulfoxide complexes
  129. Probing intermolecular interactions in a diethylcarbamazine citrate salt by fast MAS 1 H solid-state NMR spectroscopy and GIPAW calculations
  130. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells
  131. Spectroscopic (far or terahertz, mid-infrared and Raman) investigation, thermal analysis and biological activity of piplartine
  132. Synthesis, structural characterization and cytotoxic activity against tumor cells of heteroleptic copper (I) complexes with aromatic diimines and phosphines
  133. Ru(II)/diphenylphosphine/pyridine-6-thiolate complexes induce S-180 cell apoptosis through intrinsic mitochondrial pathway involving inhibition of Bcl-2 and p53/Bax activation
  134. Photochemical studies of cis -[Ru(bpy) 2 (4-bzpy)(CO)](PF 6 ) 2 and cis -[Ru(bpy) 2 (4-bzpy)(Cl)](PF 6 ): Blue light-induced nucleobase binding
  135. Ruthenium(II)/triphenylphosphine complexes: An effective way to improve the cytotoxicity of lapachol
  136. Development of a salt drug with improved solubility: Ethionamide nitrate
  137. Propyl gallate metal complexes: Circular dichroism, BSA-binding, antioxidant and cytotoxic activity
  138. Hydroxycalciomicrolite, Ca1.5Ta2O6(OH), a new member of the microlite group from Volta Grande pegmatite, Nazareno, Minas Gerais, Brazil
  139. Reducing the Hygroscopicity of the Anti-Tuberculosis Drug (S,S)-Ethambutol Using Multicomponent Crystal Forms
  140. Reactive nitrogen/oxygen species production by nitro/nitrosyl supramolecular ruthenium porphyrin complexes
  141. Copper(I)–Phosphine Polypyridyl Complexes: Synthesis, Characterization, DNA/HSA Binding Study, and Antiproliferative Activity
  142. Syntheses, characterization and antifungal activity of novel dimethylbis(N-R-sulfonyldithiocarbimato)stannate(IV) complexes
  143. Order–disorder phase transition induced by proton transfer in a co-crystal of 2,4-dichlorobenzoic acid and trimethylamine N-oxide
  144. A Potential Visible-Light NO Releaser: Synthesis, Reactivity and Vasodilator Properties
  145. Polypyridyl Ruthenium Complexes: Novel DNA-Intercalating Agents against Human Breast Tumor
  146. Structural isomerism of Ru(ii)-carbonyl complexes: synthesis, characterization and their antitrypanosomal activities
  147. Studies on the Ru(II) monocationic complexes [RuCl 2 (NO)(P–N)(PR 3 )]PF 6 , where P–N = o -diphenylphosphino- N , N -dimethylaniline, and R = Ph and p -X-C 6 H 4 (X = OMe, Me, F)
  148. Ru(II)/bisphosphine/diimine/amino acid complexes: diastereoisomerism, cytotoxicity, and inhibition of tumor cell adhesion to collagen type I
  149. Correction to Rare Case of Polymorphism in a Racemic Fluoxetine Nitrate Salt: Phase Behavior and Relative Stability
  150. Solution and Solid State Nuclear Magnetic Resonance Spectroscopic Characterization of Efavirenz
  151. X-Ray diffraction, spectroscopy and thermochemical characterization of the pharmaceutical paroxetine nitrate salt
  152. Diffractaic acid: Crystalline structure and physicochemical characterization
  153. On the Thermal Stability of the Diethylcarbamazine-Fortified Table Salt Used in the Control of Lymphatic Filariasis
  154. Rare Case of Polymorphism in a Racemic Fluoxetine Nitrate Salt: Phase Behavior and Relative Stability
  155. Centrosymmetric resonance-assisted intermolecular hydrogen bonding chains in the enol form of β-diketone: Crystal structure and theoretical study
  156. Syntheses, characterization and antifungal activity of heteroleptic nickel(II) complexes with N-alkylsulfonyldithiocarbimates and phosphines
  157. Cationic Pd(II) complexes acting as topoisomerase II inhibitors: Synthesis, characterization, DNA interaction and cytotoxicity
  158. Reversible Solid-State Hydration/Dehydration of Paroxetine HBr Hemihydrate: Structural and Thermochemical Studies
  159. Looking for the interactions between omeprazole and amoxicillin in a disordered phase. An experimental and theoretical study
  160. Tetraphenylphosphonium allyldithiocarbimates derived from Morita-Baylis-Hillman adducts: Synthesis, characterization, crystal structure and antifungal activity
  161. Tuning the structure, dimensionality and luminescent properties of lanthanide metal–organic frameworks under ancillary ligand influence
  162. Supramolecular synthesis and thermochemical investigations of pharmaceutical inorganic isoniazid salts
  163. Rare earth coordination dinuclear compounds constructed from 3,5-dicarboxypyrazolate and succinate intermetallic bridges
  164. Influence of gold nanoparticles applied to catalytic hydrogenation of acetophenone with cationic complexes containing ruthenium
  165. Mechanochemistry applied to reformulation and scale-up production of Ethionamide: Salt selection and solubility enhancement
  166. Luminescence, chemical sensing and mechanical properties of crystalline materials based on lanthanide–sulfonate coordination polymers
  167. Chiral Platinum(II) Complexes Featuring Phosphine and Chloroquine Ligands as Cytotoxic and Monofunctional DNA-Binding Agents
  168. Crystal structure of 4-formyl-2-nitrophenyl 4-chloro-2-nitrobenzoate
  169. Crystal structure of 2-(4-chlorobenzamido)benzoic acid
  170. Cis-[RuCl(BzCN)(N–N)(P–P)]PF6 complexes: Synthesis and in vitro antitumor activity
  171. Vibrational and thermal analyses of multicomponent crystal forms of the anti-HIV drugs lamivudine and zalcitabine
  172. Exploring the System Lanthanide/Succinate in the Formation of Porous Metal–Organic Frameworks: Experimental and Theoretical Study
  173. Crystal structure and catalytic activity of ruthenium (II)/dithiocarbamate complexes in the epoxidation of cyclooctene
  174. Copper(II) complexes with β-diketones and N-donor heterocyclic ligands: Crystal structure, spectral properties, and cytotoxic activity
  175. Isostructurality and the conformational role of the 2′,3′-moieties in the diversity of lamivudine crystal forms probed in halide salts
  176. Anti-Mycobacterium tuberculosisand Cytotoxicity Activities of Ruthenium(II)/Bipyridine/Diphosphine/Pyrimidine-2-thiolate Complexes: The Role of the Non-CoordinatedN-Atom
  177. Ruthenium(II) complexes with hydroxypyridinecarboxylates: Screening potential metallodrugs against Mycobacterium tuberculosis
  178. Crystal Growth & Design Celebrates the International Year of Crystallography 2014
  179. DFT investigation on hydrogen bonding in cyclohexane-1,2,3,4,5-pentol crystal structure
  180. Crystal structure of 4-bromo-N-(2-hydroxyphenyl)benzamide
  181. Crystal structure of 2-nitro-N-(5-nitro-1,3-thiazol-2-yl)benzamide
  182. Crystal structure of (±)-3-[(benzo[d][1,3]dioxol-5-yl)methyl]-2-(3,4,5-trimethoxyphenyl)-1,3-thiazolidin-4-one
  183. Temperature-Driven Isosymmetric Reversible Phase Transition of the Hormone Estradiol 17β Valerate
  184. Solid-State Supramolecular Synthesis Based on the N–H…O Heterosynthon: An Approach to Solve the Polymorphism Problem in Famotidine
  185. Saddle-shaped macrocycle distortion and symmetry decrease in cobalt (II) meso-tetraphenylporphyrin: Structure of a dichloromethane solvate and DFT calculations
  186. Effect of the Methanol Molecule on the Stabilization of C 18 H 18 O 4 Crystal: Combined Theoretical and Structural Investigation
  187. Structural features and cytotoxic activities of [Ru(AA-H)(dppb)(bipy)]PF6 complexes
  188. Synthesis, structural characterization and cytotoxic activity of ternary copper(II)–dipeptide–phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer
  189. Controlled Synthesis of New 5-Fluorocytosine Cocrystals Based on the p K a Rule
  190. Nitro/Nitrosyl-Ruthenium Complexes Are Potent and Selective Anti-Trypanosoma cruzi Agents Causing Autophagy and Necrotic Parasite Death
  191. Modified glassy carbon electrode with AuNPs using cis-[RuCl(dppb)(bipy)(4-vpy)]+ as crossed linking agent
  192. Antiparasitic activities of novel ruthenium/lapachol complexes
  193. fac-[1,2-Bis(pyridin-4-yl)ethane-κN]tricarbonyl(1,10-phenanthroline-κ2N,N′)rhenium(I) hexafluoridophosphate acetonitrile monosolvate
  194. [4-(Allyloxy)phenyl](phenyl)methanone
  195. 2,4,6-Trinitrophenyl 3-bromobenzoate
  196. 2-[(1-Oxidopyridin-4-yl)sulfanyl]benzoic acid
  197. 3-(Diphenylamino)isobenzofuran-1(3H)-one
  198. Synthesis, characterization and phytotoxic activity of hydroxylated isobenzofuran-1(3H)-ones
  199. Halogen⋯halogen contacts for the stabilization of a new polymorph of 9,10-dichloroanthracene
  200. 2,2′-(1,4-Phenylene)bis(propane-2,2-diyl) bis(benzodithioate)
  201. Quasi-enantiomeric single-nucleoside and quasi-racemic two-nucleoside hydrochloride salts and ruthenium complexes of cytidine and 2′,3′-dideoxycytidine analogs unveiling the negligible structure-driving role of the 2′,3′-moieties
  202. Unusual hydrogen bond patterns contributing to supramolecular assembly: conformational study, Hirshfeld surface analysis and density functional calculations of a new steroid derivative
  203. Novel polymorphs of the anti-Trypanosoma cruzi drug benznidazole
  204. Ruthenium(II)/4,6-dimethyl-2-mercaptopyrimidine complexes: Synthesis, characterization, X-ray structures and in vitro cytotoxicity activities on cancer cell lines
  205. Structural and vibrational study of 8-hydroxyquinoline-2-carboxaldehyde isonicotinoyl hydrazone – A potential metal–protein attenuating compound (MPAC) for the treatment of Alzheimer’s disease
  206. 4-Formyl-2-nitrophenyl 2-chlorobenzoate
  207. The Continuum in 5-Fluorocytosine. Toward Salt Formation
  208. Mebendazole Mesylate Monohydrate: A New Route to Improve the Solubility of Mebendazole Polymorphs
  209. Fluorcalciomicrolite, (Ca, Na, 〈)2Ta2O6F, a new microlite-group mineral from Volta Grande pegmatite, Nazareno, Minas Gerais, Brazil
  210. The effect of guest molecules on the conformation and molecular assembly of the fac-[RuCl3(NO)(dppb)] complex
  211. NH⋯Br, Br⋯π and π⋯π interactions toward self-assembly of the cytosine hydrobromide: Crystal structure, infrared spectroscopy and thermal behavior
  212. 2-[1′-(Benzyloxy)spiro[indane-1,2′-pyrrolidine]-5′-yl]acetonitrile
  213. (±)-3-(5-Amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-benzofuran-1(3H)-one
  214. Industrial Scale Isolation, Structural and Spectroscopic Characterization of Epiisopiloturine from Pilocarpus microphyllus Stapf Leaves: A Promising Alkaloid against Schistosomiasis
  215. 2,4,6-Trinitrophenyl 3-chlorobenzoate
  216. Supramolecular study, Hirshfeld analysis and theoretical study of 6-methoxyquinolineN-oxide dihydrate
  217. 4-Formyl-2-nitrophenyl 4-bromobenzoate
  218. X-ray Crystal Structures of Intermediates of the Stereoselective (±)-Grandisol Synthesis Based on the Remote Alkylation Protocol
  219. 2,2′-(Carbonothioyldisulfanediyl)bis(2-methylpropanoic acid)
  220. Synthesis, crystal structure and photoluminescence of a binuclear complex of europium(III) containing 3,5-dicarboxypyrazolate and succinate
  221. 2,4,6-Trinitrophenyl 4-chlorobenzoate
  222. 5-Chloroquinolin-8-yl furan-2-carboxylate
  223. Study of a series of cobalt(II) sulfonamide complexes: Synthesis, spectroscopic characterization, and microbiological evaluation against M. tuberculosis. Crystal structure of [Co(sulfamethoxazole)2(H2O)2]·H2O
  224. New ruthenium(II)/phosphines/diimines complexes: Promising antitumor (human breast cancer) and Mycobacterium tuberculosis fighting agents
  225. A new copper(II) complex with 2-thenoyltrifluoroacetone and 2,2-bipyridine: Crystal structure, spectral properties and cytotoxic activity
  226. Electrochemical and Monte Carlo studies of self-assembled trans-[Fe(cyclam)(NCS)2]+ complex ion on gold surface as electrochemical sensor for nitric oxide
  227. Hydrokenomicrolite, ( ,H2O)2Ta 2(O,OH)6(H2O), a new microlite-group mineral from Volta Grande pegmatite, Nazareno, Minas Gerais, Brazil
  228. cis-Bis(1,10-phenanthroline-κ2N,N′)bis(pyridin-4-amine-κN1)ruthenium(II) bis(hexafluoridophosphate)
  229. cis-Bis(2,2′-bipyridine-κ2N,N′)bis(pyridin-4-amine-κN1)ruthenium(II) bis(hexafluoridophosphate) acetonitrile monosolvate
  230. Understanding the Solid Forms of 5E-phenylethenylbenzofuroxan with Differentin vivoanti-T. cruziActivity
  231. 16α-Hydroxyfriedelin and 3-Oxo-16-methylfriedel-16-ene as Building Blocks: Crystal Structure and Hirshfeld Surfaces Decoding Intermolecular Contacts
  232. Novel sesquiterpene lactones from Eremanthus seidelii
  233. Crystal Structure of Limonoid 6-O-Acetylswietephragmin E and Theoretical Study of Nuclear Magnetic Resonance Spectra of Phragmalin Limonoids
  234. 3,5-Bis(benzyloxy)benzoic acid
  235. 2,4,6-Trinitrophenyl 4-methylbenzoate
  236. Base-Paired and Base-Stacked Structures of the Anti-HIV Drug Lamivudine: A Nucleoside DNA-Mimicry with Unprecedented Topology
  237. Synthesis, crystal structure and magnetic properties of the helical oxalate-bridged copper(II) chain {[(CH3)4N]2[Cu(C2O4)2] · H2O}n
  238. Ethyl 2-(3-phenylthioureido)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate
  239. Synthesis and characterization of [Ru(η6-C10H14)(dppf)X][PF6] (X=Cl, Br, I, SnF3) compounds: The X-ray structure of [Ru(η6-C10H14)(dppf)Cl][SnCl3]·0.45CH2Cl2
  240. 2,4,6-Trinitrophenyl 3-methylbenzoate
  241. 6-Bromopyridine-2-carbaldehyde phenylhydrazone
  242. Lamivudine Salts with Improved Solubilities
  243. 9-(4-Bromobutyl)-9H-carbazole
  244. Synthesis and characterization of the atropisomeric relationships of a substituted N-phenyl-bipyrazole derivative with anti-inflammatory properties
  245. Inhibition of cysteine proteases by a natural biflavone: behavioral evaluation of fukugetin as papain and cruzain inhibitor
  246. Cyclopropane- and spirolimonoids and related compounds from Hortia oreadica
  247. Host–guest interactions between xanthones and water: the role of O–H···O, C–H···O, and π···π contacts in the channel- and cage-type frameworks
  248. Pseudopolymorphism in hydroxybenzophenones: the dihydrate of 2,2′,4,4′-tetrahydroxybenzophenone
  249. Influence of hydrogen bonds on the molecular structure and conformations of two (C30H48O2) pentacyclic triterpene isomers
  250. Salts of the anti-HIV drug lamivudine with phthalic and salicylic acids
  251. Toward supramolecular architectures of the anti-HIV drug lamivudine: understanding the effect of the inclusion of water in a hydrochloride form
  252. Form III-like conformation and Form I-like packing in a chloroform channel solvate of the diuretic drug chlortalidone
  253. X-ray diffraction and theoretical investigation of the Gedunin crystal structure
  254. Preparation, characterization and structure of ruthenium phosphine complexes containing non-innocent ligands
  255. Hydrothermal syntheses of ETS-10 like vanadosilicates using chiral organic molecules. Part I
  256. 4-Methylphenyl 4-bromobenzoate
  257. Ruthenium(II) phosphine/diimine/picolinate complexes: Inorganic compounds as agents against tuberculosis
  258. Syntheses, crystal structure and theoretical investigation of novel heteroleptic complexes of nickel(II) with N-R-sulfonyldithiocarbimate and phosphine ligands
  259. Rankamaite from the Urubu pegmatite, Itinga, Minas Gerais, Brazil: Crystal chemistry and Rietveld refinement
  260. Weak C—H...Cl—Pd interactions toward conformational polymorphism intrans-dichloridobis(triphenylphosphane)palladium(II)
  261. A monoclinic polymorph of the ticlopidine hydrochloride
  262. Crystal structure of the drug diethylcarbamazine and a new maleate salt
  263. Supramolecular chemistry of anti-HIV nucleoside drugs: toward smart crystal phases and self-assembled DNA-mimicries
  264. Asymmetric heterobimetallic mixed-valence complex trans-[(SO3)Co(cyclam)(NCS)Ru(NH3)4(NCS)](BF4): Synthesis and characterization
  265. Experimental and theoretical investigation of molecular structure and conformation of the 4-isopropylthioxanthone
  266. fac-/mer-[RuCl3(NO)(P–N)] (P–N=[o-(N,N-dimethylamino)phenyl]diphenylphosphine): Synthesis, characterization and DFT calculations
  267. Conformational polymorphism of the antidiabetic drug chlorpropamide
  268. cis-Bis[1,1-dibenzyl-3-(furan-2-ylcarbonyl)thioureato-κ2O,S]copper(II)
  269. THE CRYSTAL STRUCTURE OF A MICROLITE-GROUP MINERAL WITH A FORMULA NEAR NaCaTa2O6F FROM THE MORRO REDONDO MINE, CORONEL MURTA, MINAS GERAIS, BRAZIL
  270. Study of the phenanthroline-Mn-imidazole bonding in Mn(I) triscarbonyl complex: A X-ray and DFT computational analysis
  271. cis-Bis{1,1-dibenzyl-3-[(furan-2-yl)carbonyl]thioureato-κ2O,S}nickel(II)
  272. Tetrachlorocarbonyliridates: Water-Soluble Carbon Monoxide Releasing Molecules Rate-Modulated by the Sixth Ligand
  273. Synthesis and Crystal Structures of Octahedral Sn(IV) Complexes Prepared from SnCl2·2H2O and 2-Hydroxyacetophenone (S-benzydithiocarbazate) Ligand (H2L)
  274. 4-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoic acid: X-ray and DFT-calculated structure
  275. Design of 1D and 2D molecule-based magnets with the ligand 4,5-dimethyl-1,2-phenylenebis(oxamato)
  276. Increasing the symmetry of drug crystals: a monoclinic conformational polymorph of the platelet antiaggregating agent ticlopidine hydrochloride
  277. The mer-[RuCl3(dppb)(H2O)] complex: A versatile tool for synthesis of RuII compounds
  278. 2-(Phenylcarbonothioylsulfanyl)acetic acid
  279. 3-Nitrophenol–4,4′-bipyridylN,N′-dioxide (2/1): a DFT study and CSD analysis of DPNO molecular complexes
  280. Triple Structural Transition below Room Temperature in the Antifilarial Drug Diethylcarbamazine Citrate
  281. Coordination of nitro-thiosemicarbazones to ruthenium(II) as a strategy for anti-trypanosomal activity improvement
  282. On the synthesis and structures of the complexes [RuCl(L)(dppb)(N–N)]PF6 (L=CO, py or 4-NH2py; dppb=1,4-bis(diphenylphosphino)butane; N–N=2,2′-bipyridine or 1,10-phenanthroline) and [(dppb)(CO)Cl2-Ru-pz-RuCl2(CO)(dppb)] (pz=pyrazine)
  283. Oxorhenium(V) Complexes with 2,3-Dihydroxynaphthalene
  284. 2-[(2-Carboxyphenyl)disulfanyl]benzoic acid–4,4′-bipyridylN,N′-dioxide (1/2)
  285. ChemInform Abstract: 6-Deoxyjacareubin.
  286. ChemInform Abstract: Serendipitous, One-Pot Formation of 2,3,7-Triphenylcyclopenta[c]pyran from 1,2-Diphenylethanedione (“Benzil”) and Cyclopentadiene.
  287. Synthesis, characterization and cytotoxic activities of the [RuCl2(NO)(dppp)(L)]PF6 complexes
  288. Solvothermal Preparation of Drug Crystals: Didanosine
  289. From Rational Design of Drug Crystals to Understanding of Nucleic Acid Structures: Lamivudine Duplex
  290. Structural and magnetic properties of the oxyborateCo5Ti
  291. On the relationships between molecular conformations and intermolecular contacts toward crystal self-assembly of mono-, di-, tri-, and tetra-oxygenated xanthone derivatives
  292. Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity
  293. Dependence of the product on the P–P ligand in reactions of [RuCl3(NO)(P–P)] complexes (P–P=aromatic diphosphines) with 2-mercaptopyridine
  294. Experimental and theoretical study of the kinetics of dissociation in cis-[RuCl2(P-P)(N-N)] type complexes
  295. Efficient synthesis of benzothiazine and acrylamide compounds
  296. A novel and simple synthetic route for a piperazine derivative
  297. Palladium(II) complexes with thiosemicarbazones: syntheses, characterization and cytotoxicity against breast cancer cells and Anti-Mycobacterium tuberculosis activity
  298. Crystal Engineering of an Anti-HIV Drug Based on the Recognition of Assembling Molecular Frameworks
  299. Structural relationships in the solid state of the anti-chagas agent (E)-phenylethenylbenzofuroxan
  300. Driving forces in substitution reactions of octahedral complexes: The influence of the competitive effect
  301. Synthesis, structural characterization and ex vivo biological properties of a new complex [Cu(propranolol)2]·2H2O, a potential beta-blocker
  302. Imidazolium fumarate
  303. Heterobimetallic compounds [Ru(η5-Cp)(dppf)X] (X = Cl, Br, I and N3): synthesis, electrochemical analysis, and the crystal structure of [Ru(η5-Cp)(dppf)I] [dppf = 1,1′-bis(diphenylphosphino)ferrocene]
  304. Bis(tetraphenylphosphonium) tris[N-(methylsulfonyl)dithiocarbimato(2−)-κ2S,S′]stannate(IV)
  305. Synthesis, characterization, and single crystal X-ray structure of the 1-furoyl-3-cyclohexylthiourea cadmium chloride complex, Cd[C4H3OC(O)NHC(S)NHC6H11]4Cl2
  306. Intermolecular contacts influencing the conformational and geometric features of the pharmaceutically preferred mebendazole polymorph C
  307. Conformational Polymorphism in Racemic Crystals of the Diuretic Drug Chlortalidone
  308. 3-Nitrobenzoic acid–3-methyl-4-nitropyridine 1-oxide (1/1)
  309. On an Electrode Modified by a Supramolecular Ruthenium Mixed Valence (Ru II /Ru III ) Diphosphine-Porphyrin Assembly
  310. Molecular conformation of the racemic indan derivative (±)-1-trans-3-(3,4-dichlorophenyl)-2,3-dihydro-1H-indene-1-carboxamide
  311. 4-{2-[4-(Dimethylamino)phenyl]ethylidene}benzonitrile
  312. Partial magnetic ordering and crystal structure of the ludwigitesCo2
  313. 1-Furoyl-3-[3-(trifluoromethyl)phenyl]thiourea
  314. Diphenyllead(IV) thiosemicarbazonates and pyrazolonates: Synthesis and characterization
  315. Redetermination of 1-benzyl-3-furoyl-1-phenylthiourea
  316. Preparation of Achiral and Chiral (E)-Enaminopyran-2,4-diones and Their Phytotoxic Activity
  317. Spectroscopic Investigation on the Formation of a Dinuclear Me2SO–Ru2-Mercaptopyridine Bridged Complex: [Ru2Cl3(μ-pyS)(μ-dmso)(dmso)4] · 2H2O
  318. Lupeol
  319. Vanadium complexes with thiosemicarbazones: Synthesis, characterization, crystal structures and anti-Mycobacterium tuberculosis activity
  320. Novel 6-methanesulfonamide-3,4-methylenedioxyphenyl-N-acylhydrazones: Orally effective anti-inflammatory drug candidates
  321. Synthesis, structural characterization and conformational aspects of nostoclide analogues
  322. Organotin Complexes of Alizarin and Purpurin
  323. Different coordination modes for disulfoxides towards diorganotin(IV) dichlorides. X-ray crystal structures of 1,2-cis-bis-(phenylsulfinyl)ethene (rac-,cis-cbpse) and adducts [{Ph2SnCl2(meso-bpse)}n] and [{n-Bu2SnCl2(pdtd)}2]
  324. Study of the [Zn(H2O)4CuEDTA]·2H2O Complex, a Potential Trace-metal Supplier: Synthesis, Crystal Structure, Spectroscopic Behavior and Metal Release
  325. Analyzing Ru(III)–dmso and Ru(III)–dms motifs in compounds used in the synthesis of the antimetastatic agents
  326. N-(4-Chlorophenyl)maleimide
  327. Rhenium chelate complexes with maltolate or kojate
  328. Synthesis, characterization, X-ray structure and in vitro antimycobacterial and antitumoral activities of Ru(II) phosphine/diimine complexes containing the “SpymMe2” ligand, SpymMe2=4,6-dimethyl-2-mercaptopyrimidine
  329. Powder X-ray diffraction study of polymorphic drugs: fluconazole and mebendazole
  330. 1-(o-Tolyl)thiourea
  331. N-(2-Furylcarbonyl)piperidine-1-carbothioamide
  332. 1-(2-Furoyl)-3-(o-tolyl)thiourea
  333. Crystal Structure of Garciniaphenone and Evidences on the Relationship between Keto-Enol Tautomerism and Configuration
  334. Hydrogen bonding in 2-(2-oxothiazolidin-3-yl)-4,5-dihydrothiazolium hydrogen sulfate monohydrate
  335. 1-(3-Cyanophenyl)-3-(2-furoyl)thiourea
  336. Quantum-chemical, NMR and X-ray diffraction studies on (±)-1-[3,4-(methylenedioxy)phenyl]-2-methylaminopropane
  337. 1-Furfuryl-3-furoylthiourea
  338. Structure and magnetism of homometallic ludwigites:Co3O
  339. Synthesis and Characterization of a New Copper(II) Complex with Nadolol, an Aminoalcoholic Beta-blocker. Crystal Structure of Na[Cu(nadololate)(CO3)] · H2O
  340. N-(3-Chlorophenyl)maleimide
  341. 8-Hydroxy-5,6,7-trimethoxy-2-phenyl-4H-chromen-4-one
  342. Lead(II)-induced formation and coordination of 3,4-dihydro-3-thioxo-1,2,4-triazin-5(2H)-one
  343. Dimethylthallium(III) complexes with picolinic acid and its hydroxyl derivatives
  344. Ruthenium(II) complexes containing N(4)-tolyl-2-acetylpyridine thiosemicarbazones and phosphine ligands: NMR and electrochemical studies of cis–trans isomerization
  345. Crystal Structures and Thermal Behavior of Alkaline Earth Tricyanomethanides
  346. New Ni(II)-sulfonamide complexes: Synthesis, structural characterization and antibacterial properties. X-ray diffraction of [Ni(sulfisoxazole)2(H2O)4]·2H2O and [Ni(sulfapyridine)2]
  347. Menezesite, the first natural heteropolyniobate, from Cajati, Sao Paulo, Brazil: Description and crystal structure
  348. Synthesis and Characterization of a New Mebendazole Salt: Mebendazole Hydrochloride
  349. New insights on the Lewis acidity of diorganolead(IV) compounds: Diphenyllead(IV) complexes with N,O,S-chelating ligands
  350. Synthesis of novel O-acylated-D-ribono-1,5-lactones and structural assignment supported by conventional NOESY-NMR and x-ray analysis
  351. Sobre uma degenerescência acidental nos deslocamentos químicos de RMN de 31P{¹H} em complexos difosfínicos de rutênio
  352. Crystalline Structure of Mangiferin, aC-Glycosyl-Substituted 9H-Xanthen-9-one Isolated from the Stem Bark ofMangifera indica
  353. New Pd(II) and Pt(II) complexes with N,S-chelated pyrazolonate ligands: Molecular and supramolecular structure and preliminary study of their in vitro antitumoral activity
  354. Novel manganese (III) porphyrin containing peripheral “[RuCl(dppb)(X-bipy)]+” cations [dppb=1,4-bis(diphenylphosphino)butane and X=–CH3, –OMe, –Cl]. X-ray structure of the cis-[RuCl(dppb)(bipy)(4-Mepy)]PF6 complex
  355. Low-temperature study of a new nevirapine pseudopolymorph
  356. 2-Benzoylpyridine semicarbazone
  357. Synthesis, characterization and crystal structure of a novel thiocyanate–ruthenium(II) complex
  358. Heterobimetallic [Ru(II)/Fe(II)] complexes: On the formation of trans- and cis-[RuCl2(dppf)(diimines)]
  359. Synthesis, characterization, X-ray structure and preliminary in vitro antitumor activity of the nitrosyl complex fac-[RuCl3(NO)(dppf)], dppf=1,1′-bis(diphenylphosphine)ferrocene
  360. Crystal structure, electrochemical and photochemical studies of the trans-[Fe(cyclam)(NO)Cl]Cl2 complex (cyclam=1,4,8,11-tetraazacyclotetradecane)
  361. New lead(II) complexes with N,S-ligands, including a lead pyrazolonate with unusual packing flexibility
  362. Crystal structure and anticonvulsant activity of (±)-1,2:4,5-di-O-isopropylidene-3,6-di-O-(2-propylpentanoyl)-myo-inositol
  363. X-ray structure and EPR behavior of a new dimeric copper(II) complex with 4-amino-N-(5-methoxy-2-pyrimidinyl)benzenesulfonamide
  364. Methyllead(IV) Derivatives Stabilized by DAPTSC2–: Synthesis and Structures of New Diorganolead(IV) Complexes
  365. Novel Gold(I) 7-Azacoumarin Complex:  Synthesis, Structure, Optical Properties, and Cytotoxic Effects
  366. Synthesis and structural characterization of two nostoclide analogues
  367. Correlation between quadrupole splitting (Δ) and the θ angle (C–Sn–C) in five-coordinate diphenyltin(IV) complexes. X-ray crystal structures of [Ph2Sn(hacm)] and [Ph2Sn(hacmm)] containing O,N,S-tridentate N 4-heterocyclic thiosemicarbazones
  368. 2,2′,4-Trihydroxybenzophenone: Crystal Structure, and Anti-Inflammatory and Antioxidant Activities
  369. Physicochemical characterization of deflazacort: Thermal analysis, crystallographic and spectroscopic study
  370. The preparation of new oxoniobium(V) complexes from hydrated Niobium(V) Oxide: the crystal and molecular structure of Oxotris(2-pyridinolato-N-oxide)niobium(V)
  371. Pseudohalides of Main Group Metals: The Alcaline Earth Tricyanomethanides - The Crystal Structures of Calcium and Barium Tricyanomethanide.
  372. Natural polyprenylated benzophenones: keto-enol tautomerism and stereochemistry
  373. The first P–N containing RuCl3NO complex: fac-[RuCl3(NO)(P–N)] (P–N=[o-(N,N-dimethylamino)phenyl]diphenylphosphine)
  374. Novel zwitterionic oxorhenium(V) complexes: synthesis, characterization and crystal structure of [ReOX2(Hdhp)(PPh3)] (X = Cl, Br; H2dhp = 2,3-dihydroxypyridine)
  375. Matioliite, the Mg-analog of burangaite, from Gentil mine, Mendes Pimentel, Minas Gerais, Brazil, and other occurrences
  376. A gold(I) complex with a vitamin K3 derivative: Characterization and antitumoral activity
  377. 7-Amino-1-(3-bromophenyl)-3-cyanopyrazolo[4,3-d]pyrimidine
  378. A duplicated nitrotienyl derivative with antimycobacterial activity: synthesis, X-ray crystallography, biological and mutagenic activity tests
  379. Structural characterization of a series of new Cu-dipeptide complexes in solid state and in solution
  380. Magnetic properties of copper(II) complexes containing peptides. Crystal structure of [Cu(phe-leu)]
  381. Synthesis, 119Sn Mössbauer spectroscopic studies and X-ray crystal structure determination of new seven-coordinate diorganotin(IV) complexes with S,N,N,N,S-pentadentate Schiff bases derived from 2,6-diacetylpyridine of S-methyl- and S-benzyldithiocarba...
  382. On a ruthenium nitrosyl and monocoordinated biphosphine monoxide complex: Synthesis, characterization and X-ray structure of
  383. Preparation, crystal structure and spectroscopic characterization of nickel(II) complexes with dithiocarbimate derivated of sulfonamides
  384. Copper complexes with heterocyclic sulfonamides: Synthesis, spectroscopic characterization, microbiological and SOD-like activities: Crystal structure of [Cu(sulfisoxazole)2(H2O)4]·2H2O
  385. Structure and Vasorelaxant Activity of Floranol, a Flavonoid Isolated from the Roots ofDioclea grandiflora
  386. Influence of ligands on the isomerization in [RuCl3(NO)(P–P)] complexes, [P–P=R2P(CH2)nPR2 (n=1–3) and R2P(CH2)POR2, PR2–CHCH–PR2, R=Ph and (C6H11)2P-(CH2)2-P(C6H11)2]
  387. Mammeigin
  388. Polymorphism on Leflunomide: Stability and Crystal Structures
  389. The versatility of the 1,4-dithiane ligand towards the coordination chemistry of ruthenium-phosphine complexes
  390. The role of solvent in coordination polymers: The structures of catena-[Hg(μ2-O2PPh2)2] and catena-[Hg(μ2-O2PPh2)2(NC5H5)2]
  391. Experimental and theoretical structure characterization of two isoniazid derivatives: 2,4-Difluoro-N′-isonicotinoylbenzohydrazide and 2,4-dichloro-N′-isonicotinoylbenzohydrazide hydrochloride
  392. Ruthenium Phosphine/Diimine Complexes: Syntheses, Characterization, Reactivity with Carbon Monoxide, and Catalytic Hydrogenation of Ketones.
  393. Bis(diphenylphosphinato-κO)bis(diphenylphosphinic acid-κO)bis(pyridine-κN)mercury(II)
  394. Mono- and dinuclear copper(I) complexes with methyl-substituted pyrimidinethiones
  395. A pentacyclic triterpene from Maytenus imbricata: structure elucidation by X-ray crystallography
  396. Synthesis, characterisation and molecular structure of stannyl derivatives of molybdenum and iron
  397. Zinc(II), cadmium(II) and mercury(II) complexes of the vitamin B1 antagonist oxythiamine
  398. Synthesis, characterization and structure of ruthenium(II) phosphine complexes with N-heterocyclic thiolate ligands
  399. A Crystalline Phase Transition and Optical Properties in a CoIICuII Oxamato-Bridged Ferrimagnetic Chain
  400. Ruthenium Phosphine/Diimine Complexes:  Syntheses, Characterization, Reactivity with Carbon Monoxide, and Catalytic Hydrogenation of Ketones†
  401. The RuCl3(dppb)H2O complex: A new metal-assisted oxidative dehydrogenation of the o-phenylenediamine ligand
  402. Leaf-cutting ants toxicity of limonexic acid and degraded limonoids from Raulinoa echinata.: X-ray structure of epoxy-fraxinellone
  403. Limonoids from Spiranthera odoratissima St. Hil
  404. Synthesis and characterization of nitrosyl complexes containing 4,6-dimethyl-pyrimidine-2-thiolato (‘SpymMe2’) as ligand: [Ru(‘SpymMe2’,-N,-S) (‘SpymMe2’,-S)(NO)(P–P)](PF6) (P–P=1,2-bis(diphenylphosphino)ethane or 1,2-bis(diphenylphosphino)ethylene
  405. Magnetic and structural properties of two open-frameworks Nd(III) adipates
  406. Structural insights of a potential inhibition against leishmania major
  407. Factors determining polymorphism of leflunomide
  408. Magnetic and structural properties of rare earth hybrid frameworks
  409. Experimental electron density of [Cu(phen)2Cl](NO3)(H2O)
  410. An Alternative Method for the Preparation of Diphenylboron Chelates. The Crystal and Molecular Structures of (Pyridine-2-acetyloximato)diphenylboron and (1-Phenylazo-2-naphtholato)diphenylboron
  411. Molecular and Supramolecular Structures of 1-Phenyl-4-phenylacetyl-2-thiosemicarbazide (H2L) and its Complexes with Diphenyllead(IV) Chloride and Acetate
  412. Electron density distribution in the pyroborateMn2B...
  413. 5-Nitro-2-furaldehydeN-(hydroxymethyl)semicarbazone
  414. Ruthenium complexes containing the hemilabile ligand PPh2(CH2)P(O)PPh2 (dppmO): reactivity towards CO and X-ray molecular structures of tcc-RuCl2(η2-dppmO)2 and mer-RuCl3(η1,η2-dppmO)2
  415. New pyrone and quinoline alkaloid from Almeidea rubra and their trypanocidal activity
  416. The synthesis and characterisation of Sn(IV) complexes of 2,6-pyridine dicarboxylate — the molecular structure of divinyltin(IV) derivative
  417. Layered poly[μ2-aqua-μ3-dimethylformamide-di-μ3-phenylphosphonato-dipotassium]
  418. Synthesis, characterization, and structure of a new N-nitrosamine of cyclam (1,4,8,11-tetraazacyclotetradecane)
  419. 31P{1H}-n.m.r. as a tool for identification of ruthenium isomers containing PPh3 or 1,4-bis(diphenylphosphino)butane ligands. X-ray structures of the cis-{RuCl2(PPh3)2 [4,4′-(-X)2-2,2′-bipy]} complexes [X=-H, -Me, -SMe and (-Cl, -Me)]
  420. Candesartan cilexetil, an antihypertensive agent containing an extended double ester chain
  421. mer-[RuCl3(P–P)H2O] (P–P=dppb or diop) as a starting material for the synthesis of binuclear complexes. Crystallographic structures of [(dppb)ClRu–μ(Cl)3–RuCl(dppb)] and [(η6-C6H6)Ru–μ(Cl)3–RuCl(dppb)].Imine hydrogenation using mono- and binuclear ruth...
  422. Polymeric chains, hydrogen bonds and magnetism in Nd(III) adipates
  423. Aurapten, a coumarin with growth inhibition against Leishmania major promastigotes
  424. Neo-clerodane diterpenoid, a new metalloprotease snake venom inhibitor from Baccharis trimera (Asteraceae): anti-proteolytic and anti-hemorrhagic properties
  425. mer-[RuCl3(P–P)H2O] (P–P=dppb or diop) as a starting material for the synthesis of binuclear complexes. Crystallographic structures of [(dppb)ClRu–μ(Cl)3–RuCl(dppb)] and [(η6-C6H6)Ru–μ(Cl)3–RuCl(dppb)].
  426. Syntheses, characterization and X-ray structure of potassium hydrotris(2-mercaptothiazolyl)borate, KMt, and potassium hydrotris(methimazole)borate, KTm
  427. N2,S-versus N3,S-coordination in thiosemicarbazonate complexes: only a steric influence?
  428. Crystal structure and spectral characterization of dimethylthallium (III) complexes with 2-mercaptonicotinic acid and esters
  429. The effect of the cation substitution on the structural and vibrational properties of Cs2NaGaxSc1−xF6 solid solution
  430. Crystal structure and vibrational spectrum of the NaCaMg2F7 pyrochlore
  431. The synthesis and structural characterisation of [Ru(η-Cp)(dppf)SnBr3]
  432. Synthesis, characterisation and thermal decomposition of tin(IV) dithiocarbamate derivatives – single source precursors for tin sulfide powders
  433. Synthesis, Structural, Spectroscopic and Electrochemical Characterization of New Ruthenium(II) Tetramer Complexes Containing 1,4-Bis(diphenylphosphine)butane and Alterdentate Ligands
  434. Reaction of R(Ph)SnCl2(R=Me, Et) with 2,6-diacetylpyridine bis(thiosemicarbazone) (H2DAPTSC): the crystal structures of [Me(Ph)Sn(HDAPTSC)]Cl·1.25 MeOH and [Et(Ph)Sn(H2DAPTSC)]Cl2·MeOH·H2O
  435. Crystallographic report: Supramolecular structure of 2-aminonicotinatodimethylthallium(III),[TlMe2(2anic)]n
  436. Preparation, crystal structure and spectroscopic characterization of novel N-R-sulfonyldithiocarbimate platinum(II) complexes
  437. The Reaction of Dimethyltin(IV) Dichloride with Thiamine Diphosphate (H2TDP):  Synthesis and Structure of [SnMe2(HTDP)(H2O)]Cl·H2O, and Possibility of a Hitherto Unsuspected Role of the Metal Cofactor in the Mechanism of Vitamin-B1-Dependent Enzymes
  438. Structural, spectroscopic and redox studies of a new ruthenium(III) complex with an imidazole-rich tripodal ligand
  439. The Zn2+salt of pamidronate: a role for water in the metal–cation binding properties of bisphosphonates
  440. Crystallographic report: Ethyltriphenyltin(IV), Et(Ph)3Sn
  441. Potassium tetrakis(2-mercaptothiazolyl)borate; an open-framework material: synthesis and X-ray structure analysis
  442. A new monoclinic polymorph of methylp-aminobenzoate
  443. New thallium(III) chloride complexes with pyridine carboxylic acids: from molecular compounds to supramolecular associations
  444. Synthesis, crystal structures and spectroscopic properties of dichloroethylphenyltin(IV) and its phenanthroline adduct
  445. Dichloro(diphosphine)(2-pyridyl-ketone)ruthenium(II) complexes
  446. New Crystals in the Lithium Sulfate Family.
  447. 3-(5,7-Dimethoxy-2,2-dimethyl-2H-benzo[b]pyran-6-yl)propionic acid: a potential inhibitor against Leishmania
  448. Redetermination of skimmianine: a new inhibitor against the Leishmania APRT enzyme
  449. Redetermination and comparative structural study of isopimpinellin: a new inhibitor against the Leishmania APRT enzyme
  450. New crystals in the lithium sulfate family
  451. Design, Synthesis, and Evaluation of Analogues of 3,3,3-Trifluoro-2-Hydroxy-2-Phenyl-Propionamide as Orally Available General Anesthetics
  452. 3-(Benzoxazol-2-yl)-7-hydroxychromen-2-one methanol solvate
  453. Two members of the bisphosphonate class of drugs: a zwitterion and a molecular compound
  454. 2-Cyano-N-(2-hydroxyphenyl)acetamide
  455. Compositional and Structural Variety of Diphenyllead(IV) Complexes Obtained by Reaction of Diphenyllead Dichloride with Thiosemicarbazones
  456. Structure and magnetism ofMnMgB2
  457. 17α,21-Dihydroxy-16β-methylpregna-1,4-diene-3,11,20-trione (meprednisone)
  458. 4-(2-Isonicotinoylhydrazino)-4-oxobutanoic acid
  459. Synthesis and characterization of new ruthenium complexes with active ligands against Chagas' disease
  460. Redetermination of nickel bis(dithiocarbamate) at 100 K
  461. Synthesis, Spectroscopic and Structural Aspects of Mono‐ and Diorganothallium(III) Complexes of 2, 6‐Diacetylpyridine Bis(thiosemicarbazone) (H2DAPTSC) — A New Coordination Mode of the HDAPTSC— Anion
  462. 3-Oxoolean-12-en-20-yl α-methylcarboxylate
  463. A novel diterpene lactone
  464. fac-[RuCl3(NO)(dppb)] (I) and mer-[RuCl3(NO)(diop)] (II) complexes: syntheses, characterization and X-ray structures
  465. Novel Organophosphorus Cage Compound Produced by an Unexpected Oxidative Coupling of 1,2,4-Triphosphole: Crystal and Molecular Structures of Two Isomers of Formula P6C4Bu t4 CHSiMe3
  466. Syntheses, characterization and X-ray structures of the fac-[RuCl3(NO)(dppe)] and the trans-[RuCl(NO)(dppe)2]2+ species
  467. Charge density study of hexaaquazinc(II) dihydrogen-1,2,4,5-benzenetetracarboxylate
  468. Supramolecular organization in ruthenium complexes
  469. Supramolecular arrangement in dimethyl thallium complexes through Tl...S
  470. Crystal structure of cobalt-based chain molecular magnet CoCu(opba)(DMSO)3at room temperature and 100 K
  471. New Cages Derived from 1,2,4-Triphosphol
  472. Losartan potassium, a non-peptide agent for the treatment of arterial hypertension
  473. On the lability of dimethylsulfoxide (DMSO) coordinated to the {RuII–NO+} species: X-ray structures of mer-[RuCl3(DMSO)2(NO)] and mer-[RuCl3(CD3CN)(DMSO)(NO)]
  474. Single-crystal structure determination and infrared reflectivity study of the Li2CaHfF8 scheelite
  475. Crystal structure, electrochemical and spectroscopic properties of the trans-K{[FeCl(NO0)(cyclam)]·[FeCl(NO+)(cyclam)]2}(PF6)6 complex
  476. Metal-Induced Cyclization of Thiosemicarbazones Derived from β-Keto Amides and β-Keto Esters:  Open-Chain and Cyclized Ligands in Zinc(II) Complexes
  477. Supramolecular self-assembly in the crystal structures of methylmercury xanthates, MeHgS(S)COR, R=Et, iPr and CH2Ph
  478. Disodium pamidronate
  479. Synthesis and structure of cadmium and zinc complexes of dehydroacetic acid
  480. Epikatonic acid fromAustroplenckia populnea: structure elucidation by 2D NMR spectroscopy and X-ray crystallography
  481. Serendipitous, one-pot formation of 2,3,7-triphenylcyclopenta[c]pyran from 1,2-diphenylethanedione (“benzil”) and cyclopentadiene
  482. Structural Transition and Pair Formation inFe3
  483. 6-Deoxyjacareubin
  484. 1-(2-{4-[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiol-3-ylcarbonyl]phenoxy}ethyl)piperidinium chloride
  485. Role of the Hydrogen Bonds in Nitroanilines Aggregation:  Charge Density Study of 2-Methyl-5-nitroaniline
  486. A novel coordination mode for a pyridylphosphine ligand. X-ray structures of [RuCl2(NO)L] (I) and [RuCl2(NO)L]·DMSO (II) (L = [(2-py)2PC2H4POO(2-py)2]-)
  487. Structure and properties of iron–cyclam complex of 2-aminophenol
  488. THE CRYSTAL STRUCTURE OF DICHLORODIPHENYLBIPYRIDINE LEAD(IV), [PbPh2Cl2(bipy)]
  489. THE CRYSTAL STRUCTURE OF DIBROMOBIPYRIDINELEAD(II), [PbBr2(bpy)]
  490. THE CRYSTAL STRUCTURE OF DICHLORODIPHENYLPHENANTHROLINELEAD(IV), [PbPh2Cl2(phen)]
  491. Crystal structure and exchange pathways of the complex l-(trypthophyl-glycinato)copper(II)
  492. A novel coordination mode for a pyridylphosphine ligand. X-ray structures of [RuCl2(NO)L] (I) and [RuCl2(NO)L]·DMSO (II) (L = [(2-py)2PC2H4POO(2-py)2]-)
  493. Hydrogen Bonding in Nitroanilines:  Neutron Diffraction Study of m -Nitroaniline at 100 K
  494. Electrosynthesis of binuclear ruthenium complexes from [RuCl3(dppb)(L)] precursors [L = pyridine, 4-methylpyridine or dimethyl sulfoxide; dppb = 1,4-bis(diphenylphosphino)butane]
  495. Crystal structures of p-chlorobromobenzene and p-chloroiodobenzene
  496. Ba2Cu(HCOO)6, Thermal Behavior and Crystal Structure of the Room Temperature Phase
  497. Experimental evidence for the amino-group non-planarity in nitroanilines: neutron diffraction study of 2-methyl-5-nitroaniline at 100 K
  498. 3-Aryloxypropiononitriles Intermediates: Crystal and Molecular Structure of 2- and 4-(2-Bromoethoxy)diphenylmethanes
  499. 3-Aryloxypropiononitriles Intermediates: Crystal and Molecular Structure of 2- and 4-(2-Bromoethoxy)diphenylmethanes
  500. 2,4-Dinitro-N,N-methylphenylaniline
  501. 4-Benzyl-5-ethylthio-3H-1,2-dithiole-3-thione
  502. 2,4-Dinitrophenyl Phenyl Sulfone
  503. 4-Methyl-2-nitroaniline
  504. Structural studies of intermediates in a novel synthesis of aryloxypropiononitriles
  505. Conformational studies of substituted nitroanilines: geometry of 2-methyl-5-nitroaniline
  506. X-ray structural and spectroscopic investigation of 1-piperidine-2,4-dinitrobenzene